4.3 Article

Homocysteine Induces Oxidative-Nitrative Stress in Heart of Rats: Prevention by Folic Acid

期刊

CARDIOVASCULAR TOXICOLOGY
卷 11, 期 1, 页码 67-73

出版社

HUMANA PRESS INC
DOI: 10.1007/s12012-010-9094-7

关键词

Hyperhomocysteinemia; Homocysteine; Oxidative stress; Vascular damage; Cardiovascular disease

资金

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)
  2. FINEP [01.06.0842-00]
  3. Instituto Nacional de Ciencia e Tecnologia (INCT) para Excitotoxicidade e Neuroprotecao (INCT/CNPq)

向作者/读者索取更多资源

Hyperhomocysteinemia is a risk factor for cardiovascular disease, stroke, and thrombosis; however, the mechanisms by which homocysteine triggers these dysfunctions are not fully understood. In the present study, we investigated the effect of chronic hyperhomocysteinemia on some parameters of oxidative stress, namely thiobarbituric acid reactive substances, an index of lipid peroxidation, 2',7'-dichlorofluorescein (H2DCF) oxidation, activities of antioxidant enzymes named superoxide dismutase and catalase, as well as nitrite levels in heart of young rats. We also evaluated the effect of folic acid on biochemical alterations elicited by hyperhomocysteinemia. Wistar rats received daily subcutaneous injection of homocysteine (0.3-0.6 mu mol/g body weight) and/or folic acid (0.011 mu mol/g body weight) from their 6th to the 28th day of life. Controls and treated rats were killed 1 h and/or 12 h after the last injection. Results showed that chronic homocysteine administration increases lipid peroxidation and reactive species production and decreases enzymatic antioxidant defenses and nitrite levels in the heart of young rats killed 1 h, but not 12 h after the last injection of homocysteine. Folic acid concurrent administration prevented homocysteine effects probable by its antioxidant properties. Our data indicate that oxidative stress is elicited by chronic hyperhomocystenemia, a mechanism that may contribute, at least in part, to the cardiovascular alterations characteristic of hyperhomocysteinemic patients. If confirmed in human beings, our results could propose that the supplementation of folic acid can be used as an adjuvant therapy in cardiovascular alterations caused by homocysteine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据